TrialRheumatology (Oxford, England)2020

A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis.

Cynthia Aranow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.